Sign in

Filings

Finds words inside filing documents. Searching Enliven Therapeutics, Inc.'s filings · 39 documents indexed.

7 documents · 93 matches

  1. ELVN Enliven Therapeutics, Inc. 10-K 2026-03-03

    Item 1A. Risk Factors.

    tariffs, and we expect that the administration will continue with this practice. The introduction or imposition of new tariffs could
    15 matches in this document
  2. ELVN Enliven Therapeutics, Inc. 10-Q 2026-11-05

    Item 1A. Risk Factors.

    tariffs, any retaliatory actions in response thereto, taxes, and other limitations on cross-border operations, including but not limited to the provision
    13 matches in this document
  3. ELVN Enliven Therapeutics, Inc. 10-Q 2026-08-05

    Item 1A. Risk Factors.

    tariff on many imports from the European Union, with exceptions for generic medications and certain other items. While this 15% all-in tariff
    15 matches in this document
  4. ELVN Enliven Therapeutics, Inc. 10-Q 2026-05-07

    Item 1A. Risk Factors.

    tariffs preceding it, excludes certain items, as specified in Annexes to the President’s February 20, 2026 proclamation “Imposing a Temporary
    15 matches in this document
  5. ELVN Enliven Therapeutics, Inc. 10-Q 2025-11-12

    Item 1A. Risk Factors.

    tariffs could also negatively affect our ability to export and sell our potential products into those countries. If these tariffs
    12 matches in this document
  6. ELVN Enliven Therapeutics, Inc. 10-Q 2025-08-13

    Item 1A. Risk Factors.

    tariffs could also negatively affect our ability to export and sell our potential products into those countries. If these tariffs
    12 matches in this document
  7. ELVN Enliven Therapeutics, Inc. 10-Q 2025-05-14

    Item 1A. Risk Factors.

    including any trade restrictions or tariffs imposed by the United States or by other countries in response to U.S. tariffs; and
    11 matches in this document

Page 1 of 1 · 7 documents